Public trial registry of the CCC-Munich

Trial Celsion OPTIMA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Celsion OPTIMA
World
Full title
:

A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin- LTLD) in Hepatocellular Carcinoma (HCC) using standardized Radiofrequency Ablation (RFA) treatment time ? 45 minutes for solitary lesions ? 3 cm to ? 7 cm.

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 M├╝nchen Germany Tum
Indications
Classification Code Description
- C22.0 Leberzellkarzinom
Trial design
World
Phase
:
III/IV
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Ursula Ehmer Keine Organisationseinheit angegeben Magnifier